These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17180)

  • 1. Reduction of fatal graft-versus-host disease by 3H-thymidine suicide of donor cells cultured with host cells.
    Cheever MA; Einstein AB; Kempf RA; Fefer A
    Transplantation; 1977 Apr; 23(4):299-302. PubMed ID: 17180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tritiated thymidine incorporation and cell-mediated lympholysis as correlates of acute graft-versus-host reaction.
    Sharkis SJ; Strong DM; Ahmed A; Sell KW
    Exp Hematol; 1977 Nov; 5(6):443-55. PubMed ID: 22451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of increased graft-versus-host disease by mouse spleen cells sensitized in vitro to allogeneic tumor.
    Einstein AB; Cheever MA; Fefer A
    Transplantation; 1976 Dec; 22(6):589-94. PubMed ID: 12600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitivity and responsiveness to recombinant interleukin-2 of effector cells of graft vs. host disease and mixed lymphocyte reaction in mice.
    Stark J; Weiss L; Slavin S
    Isr J Med Sci; 1992 Nov; 28(11):767-72. PubMed ID: 1468887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-vs.-host reactions in reciprocal hybrid mice. I. Dissociation of T-cell activities in the mixed lymphocyte reaction and two graft-vs.-host assays.
    Morse HC; Harrison MR; Asofsky R
    J Exp Med; 1974 Mar; 139(3):721-31. PubMed ID: 4149643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
    Pierce GE
    Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation.
    Slavin S; Fuks Z; Kaplan HS; Strober S
    J Exp Med; 1978 Apr; 147(4):963-72. PubMed ID: 25942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subpopulations of mouse T lymphocytes. II. Suppression of graft-vs.-host reactions by naturally proliferating splenic T cells.
    Moorhead JW
    Eur J Immunol; 1978 Mar; 8(3):163-7. PubMed ID: 26575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of BCL1 leukemia by transplantation of low density fractions of allogeneic bone marrow and spleen cells.
    Palathumpat V; Holm B; Dejbakhsh-Jones S; Strober S
    J Immunol; 1992 May; 148(10):3319-26. PubMed ID: 1578152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.
    Xu K; Li C; Pan X; Du B
    Int J Hematol; 2007 Jul; 86(1):84-90. PubMed ID: 17675273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemotherapy of transplantable Moloney leukemia with cyclophosphamide and allogeneic spleen lymphocytes and reversal of graft-versus-host disease with alloantiserum.
    Kende M; Keys LD; Gaston M; Goldin A
    Cancer Res; 1975 Feb; 35(2):346-51. PubMed ID: 234033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of normal spleen cells on 3H-thymidine uptake by target cells in vitro.
    Nyssen J; Wang HC; Fedoroff S
    Br J Exp Pathol; 1975 Jun; 56(3):223-30. PubMed ID: 1191518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of splenectomy on graft-versus-host disease (GVHD) in mice.
    Glucksberg H; Fefer A
    J Reticuloendothel Soc; 1972 Nov; 12(5):537-44. PubMed ID: 4120362
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective elimination of alloreactive donor T cells attenuates graft-versus-host disease and enhances T-cell reconstitution.
    Gendelman M; Yassai M; Tivol E; Krueger A; Gorski J; Drobyski WR
    Biol Blood Marrow Transplant; 2003 Dec; 9(12):742-52. PubMed ID: 14677113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.
    Kirchner H; Muchmore AV; Chused TM; Holden HT; Herberman RB
    J Immunol; 1975 Jan; 114(1 Pt 1):206-10. PubMed ID: 122986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR; Pearson DA; Swenson K; Zhao G; Sachs J; Yang YG; Sykes M
    Biol Blood Marrow Transplant; 1999; 5(3):133-43. PubMed ID: 10392959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.